Bülhoff Matthias, Gurda Amina, Weishorn Johannes, Spranz David, Knappe Kevin, Raiss Patric, Trefzer Raphael
Heidelberg University, Heidelberg, Germany.
Orthopädische Chirurgie München, Munich, Germany.
Int Orthop. 2025 Aug 18. doi: 10.1007/s00264-025-06622-0.
Humeral head osteonecrosis (HHN) is a joint-destructive condition, for which cementless humeral head resurfacing (CHHR) offers a bone-preserving treatment option. The aim of this study was to report long-term outcomes and implant survival of CHHR in patients with HHN.
Patients with humeral head osteonecrosis treated with cementless humeral head resurfacing (CHHR) between 2004 and 2007 were included. Implant survival was assessed according to Kaplan-Meier analysis. Clinical evaluation included Constant-Murley-Score (CMS), Simple Shoulder Test (SST), Subjective Shoulder Value (SSV) and patient centered outcomes regarding satisfaction and quality of life. Radiographs were evaluated for glenoid erosion, Walch glenoid types as well as signs of implant loosening. Statistical comparison was performed using students t-tests with a significance level set to p < 0.05.
Seventeen shoulders were retrospectively included in the implant survival analysis. Two patients underwent revision surgery. five patients died with the implant and were therefore censored. Cumulative survival rate was 100% after ten years and 93.3% after 15 years. Seven shoulders were available for clinical and radiological evaluation at a mean follow-up of 19 years (range 17-22 years). Age- and sex-adjusted CMS improved from preoperative to the latest follow-up (44.4% vs. 82.9%; p < 0.01). No glenoid erosion of higher degree (Sperling grade > 2) and no signs of implant loosening were observed. All patients had Walch type A glenoids preoperatively.
In this small cohort with long-term follow-up of 17-22 years, CHHR showed promising durability and functional outcomes in carefully selected patients.
Level IV Case series with no comparison group.
肱骨头坏死(HHN)是一种会破坏关节的病症,非骨水泥型肱骨头表面置换术(CHHR)为其提供了一种保留骨质的治疗选择。本研究旨在报告HHN患者接受CHHR的长期疗效及植入物生存率。
纳入2004年至2007年间接受非骨水泥型肱骨头表面置换术(CHHR)治疗的肱骨头坏死患者。根据Kaplan-Meier分析评估植入物生存率。临床评估包括Constant-Murley评分(CMS)、简易肩关节测试(SST)、主观肩关节评分(SSV)以及患者对满意度和生活质量的主观评价。对X线片进行评估,观察关节盂侵蚀情况、Walch关节盂类型以及植入物松动迹象。采用学生t检验进行统计学比较,显著性水平设定为p < 0.05。
17例肩部纳入植入物生存率的回顾性分析。2例患者接受了翻修手术。5例患者植入物在位时死亡,因此被截尾。10年后累积生存率为100%,15年后为93.3%。7例肩部可进行临床和放射学评估,平均随访19年(范围17 - 22年)。年龄和性别校正后的CMS从术前到最近一次随访有所改善(44.4%对82.9%;p < 0.01)。未观察到更高程度的关节盂侵蚀(Sperling分级>2)和植入物松动迹象。所有患者术前均为Walch A型关节盂。
在这个进行了17 - 22年长期随访的小队列中,CHHR在精心挑选的患者中显示出了良好的耐用性和功能结果。
IV级 无对照组的病例系列。